M&A Transaction Summary
Produces a stakeholder-ready reference summarizing a completed or pending M&A transaction for executives, board members, investors, and employees.
Prerequisites
- Definitive agreement — purchase agreement, merger agreement, or term sheet
- Due diligence reports — financial, legal, IP, HR, environmental, tax
- Financial materials — models, fairness opinions, pro forma projections
- Integration plan — if available
- Board materials — presentations, resolutions, approvals
Quick Start
- Collect definitive agreement and all available DD reports
- Walk through each output section below, extracting from source documents
- Cross-reference all figures, dates, and defined terms against the definitive agreement
- Flag incomplete workstreams and open items with risk allocation
- Apply confidentiality legends and version control before distribution
Output Sections
1. Executive Overview (2 paragraphs max)
| Element |
Detail |
| Parties |
Buyer, seller, co-investors |
| Structure |
Asset purchase / stock purchase / merger / other |
| Total consideration |
Cash, stock, earnouts, deferred — with amounts |
| Expected closing |
Date or timeline |
| Strategic rationale |
One-sentence thesis |
2. Deal Structure & Terms
- Transaction form and rationale (tax, regulatory, liability)
- Purchase price breakdown:
| Component |
Detail |
| Cash at close |
Amount |
| Stock consideration |
Exchange ratio, collar, valuation method |
| Earnouts |
Metrics, measurement periods, caps |
| Escrow/holdbacks |
Amount, release schedule, claims process |
| Working capital adjustment |
Mechanism, target, true-up timeline |
- Assumed vs. excluded liabilities
- Deferred or contingent payment mechanics
3. Due Diligence Findings
Per workstream, capture: (a) findings supporting thesis, (b) material concerns, (c) mitigation in deal docs.
Workstreams: Financial/Accounting, Legal/Regulatory, IP/Technology, Commercial/Contracts, HR/Benefits, Environmental/Real Estate, Tax.
Flag incomplete workstreams and note risk allocation for open items.
4. Reps, Warranties & Indemnification
| Element |
Detail |
| R&W scope |
Fundamental vs. general; materiality/knowledge qualifiers |
| Survival periods |
By category |
| Indemnification basket |
Type (deductible/tipping), amount |
| Liability cap |
General vs. fundamental reps |
| Special indemnities |
Identified risks with specific coverage |
| R&W insurance |
Carrier, retention, policy limit, exclusions (if applicable) |
| Escrow |
Amount, term, release conditions |
5. Closing Conditions
Track status for each:
- HSR / antitrust clearance
- Foreign investment reviews (CFIUS, FDI)
- Industry-specific regulatory consents
- Third-party consents (customers, landlords, lenders)
- Financing condition — commitment status, market flex
- MAE provision — scope and carve-outs
- Other conditions precedent
Assess likelihood of timely satisfaction for each.
6. Integration Plan
Cover by functional area (governance, finance, HR, sales, technology, supply chain):
- Approach, timeline, key milestones
- Post-closing governance (standalone vs. integrated)
- Key employee retention mechanisms
- Regulatory or consent constraints on integration timing
7. Strategic Rationale & Value Creation
- Investment thesis (market expansion, capability acquisition, synergies)
- Synergy quantification: cost savings and revenue enhancements with estimated values and realization timelines
- Strategic fit within buyer's portfolio
- Seller rationale (if applicable)
8. Stakeholder Impact
| Stakeholder |
Impact |
| Shareholders |
Consideration, tax implications, payment timing |
| Employees |
Employment terms, benefits changes, org restructuring |
| Customers/suppliers |
Contractual continuity, service levels |
| Creditors |
Security interests, debt assumptions |
Flag uncertainties dependent on post-closing decisions.
9. Risk Factors & Mitigation
Categories: integration execution, regulatory, customer/employee attrition, financial performance, synergy realization, litigation.
For each material risk, identify the contractual protection, insurance, or operational strategy addressing it.
Pitfalls & Checks
- MNPI handling — document contains material nonpublic information; apply confidentiality legends and comply with securities laws and NDA obligations
- Forward-looking statements — label all projections and pro forma figures with cautionary language
- Cross-reference — verify all figures, dates, and defined terms against the definitive agreement
- Tone — professional and objective; not advocacy or promotional
- Audience versions — if preparing multiple versions, note redaction scope (full board vs. employee communication)
- Version control — include date and version number if the summary will be updated through closing
- Open items — identify pending negotiation points or regulatory items with expected resolution timelines
- Contact info — conclude with deal team and counsel contacts for stakeholder questions
1---2name: ma-transaction-summary3description: Generates structured M&A transaction summaries from deal documents. Triggers when the user needs to summarize a merger, acquisition, asset purchase, stock purchase, or divestiture, or when preparing board-level deal overviews from definitive agreements and due diligence materials.4---5
6# M&A Transaction Summary
7
8Produces a stakeholder-ready reference summarizing a completed or pending M&A transaction for executives, board members, investors, and employees.
9
10## Prerequisites
11
121. **Definitive agreement** — purchase agreement, merger agreement, or term sheet
132. **Due diligence reports** — financial, legal, IP, HR, environmental, tax
143. **Financial materials** — models, fairness opinions, pro forma projections
154. **Integration plan** — if available
165. **Board materials** — presentations, resolutions, approvals
17
18## Quick Start
19
201. Collect definitive agreement and all available DD reports
212. Walk through each output section below, extracting from source documents
223. Cross-reference all figures, dates, and defined terms against the definitive agreement
234. Flag incomplete workstreams and open items with risk allocation
245. Apply confidentiality legends and version control before distribution
25
26## Output Sections
27
28### 1. Executive Overview (2 paragraphs max)
29
30| Element | Detail |
31|---|---|
32| Parties | Buyer, seller, co-investors |
33| Structure | Asset purchase / stock purchase / merger / other |
34| Total consideration | Cash, stock, earnouts, deferred — with amounts |
35| Expected closing | Date or timeline |
36| Strategic rationale | One-sentence thesis |
37
38### 2. Deal Structure & Terms
39
40- Transaction form and rationale (tax, regulatory, liability)
41- Purchase price breakdown:
42
43| Component | Detail |
44|---|---|
45| Cash at close | Amount |
46| Stock consideration | Exchange ratio, collar, valuation method |
47| Earnouts | Metrics, measurement periods, caps |
48| Escrow/holdbacks | Amount, release schedule, claims process |
49| Working capital adjustment | Mechanism, target, true-up timeline |
50
51- Assumed vs. excluded liabilities
52- Deferred or contingent payment mechanics
53
54### 3. Due Diligence Findings
55
56Per workstream, capture: (a) findings supporting thesis, (b) material concerns, (c) mitigation in deal docs.
57
58Workstreams: Financial/Accounting, Legal/Regulatory, IP/Technology, Commercial/Contracts, HR/Benefits, Environmental/Real Estate, Tax.
59
60Flag incomplete workstreams and note risk allocation for open items.
61
62### 4. Reps, Warranties & Indemnification
63
64| Element | Detail |
65|---|---|
66| R&W scope | Fundamental vs. general; materiality/knowledge qualifiers |
67| Survival periods | By category |
68| Indemnification basket | Type (deductible/tipping), amount |
69| Liability cap | General vs. fundamental reps |
70| Special indemnities | Identified risks with specific coverage |
71| R&W insurance | Carrier, retention, policy limit, exclusions (if applicable) |
72| Escrow | Amount, term, release conditions |
73
74### 5. Closing Conditions
75
76Track status for each:
77- HSR / antitrust clearance
78- Foreign investment reviews (CFIUS, FDI)
79- Industry-specific regulatory consents
80- Third-party consents (customers, landlords, lenders)
81- Financing condition — commitment status, market flex
82- MAE provision — scope and carve-outs
83- Other conditions precedent
84
85Assess likelihood of timely satisfaction for each.
86
87### 6. Integration Plan
88
89Cover by functional area (governance, finance, HR, sales, technology, supply chain):
90- Approach, timeline, key milestones
91- Post-closing governance (standalone vs. integrated)
92- Key employee retention mechanisms
93- Regulatory or consent constraints on integration timing
94
95### 7. Strategic Rationale & Value Creation
96
97- Investment thesis (market expansion, capability acquisition, synergies)
98- Synergy quantification: cost savings and revenue enhancements with estimated values and realization timelines
99- Strategic fit within buyer's portfolio
100- Seller rationale (if applicable)
101
102### 8. Stakeholder Impact
103
104| Stakeholder | Impact |
105|---|---|
106| Shareholders | Consideration, tax implications, payment timing |
107| Employees | Employment terms, benefits changes, org restructuring |
108| Customers/suppliers | Contractual continuity, service levels |
109| Creditors | Security interests, debt assumptions |
110
111Flag uncertainties dependent on post-closing decisions.
112
113### 9. Risk Factors & Mitigation
114
115Categories: integration execution, regulatory, customer/employee attrition, financial performance, synergy realization, litigation.
116
117For each material risk, identify the contractual protection, insurance, or operational strategy addressing it.
118
119## Pitfalls & Checks
120
121- **MNPI handling** — document contains material nonpublic information; apply confidentiality legends and comply with securities laws and NDA obligations
122- **Forward-looking statements** — label all projections and pro forma figures with cautionary language
123- **Cross-reference** — verify all figures, dates, and defined terms against the definitive agreement
124- **Tone** — professional and objective; not advocacy or promotional
125- **Audience versions** — if preparing multiple versions, note redaction scope (full board vs. employee communication)
126- **Version control** — include date and version number if the summary will be updated through closing
127- **Open items** — identify pending negotiation points or regulatory items with expected resolution timelines
128- **Contact info** — conclude with deal team and counsel contacts for stakeholder questions
CaseMark